Abacus Group had a double treat for shareholders this morning
Abacus Group (ASX:ABP) had the most impressive response to its 1HY23 results of any companies releasing results today, not just because of the results themselves, but because it unveiled plans to de-staple (or spin-out) its Storage King assets into a separate REIT.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Abacus Group spinning out Storage King
Abacus Group is a very diversified REIT, but its flagship assets are 127 Storage King outlets throughout Australia. The new REIT, which will be known as Abacus Storage King REIT (ASX:ASK), will exclusively own these assets.
Abacus Group hopes that these assets will gain more investor attention than if they remained part of a REIT as diversified as Abacus is.
The plans will be put to shareholders at an EGM in 3Q23 and if this is approved, it is expected to be listed ‘shortly following the EGM’. Shares in Abacus Group rose by more than 8% this morning.
Abacus Property Group (ASX:ABP) share price chart, log scale (Source: TradingView)
Some FFO growth is better than none
Turning to Abacus Group’s results, the let down for shareholder was that its profit was down 73%. But its FFO (Funds from Operations) came in at $81.4m – 0.4% higher than 12 months ago, its distribution per security rose 2.9% and its NTA (net tangible assets) rose 0.3% to $3.86.
Even with this morning’s share price jump, these results place the stock at a ~20% NTA discount. It trades a P/FFO of 17x and yields 5.8% on an annualised basis, which we believe is pretty attractive.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now
FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic…
How Nuclear Energy Became the World’s Most Feared Energy Source
Why Nuclear Energy Still Scares Us and What Really Went Wrong Many investors may remember periods when nuclear energy captured…
Dateline Resources (ASX:DTR) From 60c Highs to Hard Lessons
A Rare Earth Story the Market Loved Then Questioned For investors who have followed Dateline Resources (ASX:DTR), the past year…